← FDA Drug Approvals (Drugs@FDA)
BUPIVACAINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET · Approved 2023-11-20
Drug application
- FDA Application #
ANDA217792- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BUPIVACAINE HYDROCHLORIDE
- Generic name
- BUPIVACAINE HYDROCHLORIDE
- Active ingredients
- BUPIVACAINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- SOMERSET
- Manufacturer
- Somerset Therapeutics, LLC
- First approval
- 2023-11-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown